Tracking a powerful cancer combo to improve survival

NCT ID NCT06464198

Recruiting now Disease control Sponsor: University of Erlangen-Nürnberg Medical School Source: ClinicalTrials.gov ↗

Summary

This study is creating a detailed registry to track 100 patients with advanced salivary gland cancer. The goal is to see how well patients tolerate and respond to a standard treatment that combines radiation and chemotherapy after their tumor is surgically removed. Researchers will monitor survival rates, cancer recurrence, and side effects to better understand the outcomes of this combined approach.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED SALIVARY GLAND CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Erlangen, Universitätsklinikum Strahlenklinik
RECRUITING

Erlangen, 91054, Germany

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

LOCALLY ADVANCED SALIVARY GLAND CARCINOMA